This bill (S 350) prohibits substance use disorder treatment providers - including licensed facilities and sober living homes - from using deceptive marketing practices. It requires all advertising materials to clearly state service types, locations, and provider names in plain language, banning false claims about insurance network status, locations, websites, or false relationships with other providers. Violations could result in $1,000 penalties per offense, triple damages for affected individuals, or license suspension by the Department of Health. The law directly affects treatment providers and patients seeking care, aiming to ensure transparent information for informed decisions.
S 395 ensures funding for New Jersey's Alliance to Prevent Alcoholism and Drug Abuse if state funds fall short during fiscal years 2022-2023. It requires the Governor to use federal pandemic relief funds (like CARES Act or American Rescue Plan money) to cover gaps when dedicated state revenues - collected from criminal surcharges and alcohol taxes - prove insufficient. The Alliance uses these funds to support community coalitions that run school programs, parent education, student intervention, and public awareness campaigns against substance abuse. This bill applies only to 2022-2023 and expires June 30, 2023.
New Jersey's S 2490 establishes a 12-member "Substance Use Disorder and Addiction Treatment Best Practices Task Force" within the Department of Health to address fragmentation in the state's addiction treatment system. The task force will evaluate whether a single oversight agency should replace current fragmented responsibilities (held by multiple departments), develop best practices for outpatient treatment centers and sober homes, and recommend regulations for businesses owning both services. Composed of legislative leaders, agency officials, and industry representatives (including treatment center owners and peer recovery specialists), it must submit a report to the Governor and Legislature within two years. This bill directly affects how New Jersey regulates addiction treatment providers and coordinates services across state agencies.
S 3023 protects residents of long-term care facilities (like nursing homes and assisted living facilities) and long-term acute care hospitals by preventing facility staff, owners, or financially benefiting parties from managing residents' finances or serving as their legal representatives. It requires facilities to use standardized admission forms developed by the Department of Health, with input from stakeholders, and prohibits residents from signing non-standard documents during admission. The bill also gives residents a legal right to sue if facilities violate these protections, allowing recovery of damages, attorney fees, and punitive penalties for financial exploitation. These changes directly affect residents, their families, and facility operators by creating new safeguards against financial abuse during admission and care.
This bill requires New Jersey public school districts to add instruction about social media and cell phone risks to grades 6 through 12. It expands current requirements by moving this education from technology classes (grades 6-8) to the health curriculum for all grades 6-12. The instruction must cover responsible use, cyber safety, and specifically address how addiction affects mental health, relationships, and development. School districts must implement this as part of existing health education standards, with the state providing sample resources. The bill directly affects all public school students in those grades and their schools.
This bill establishes a "Pretrial Partnership for Community Support and Services Pilot Program" in New Jersey, creating a new pathway for defendants eligible for pretrial release to access community-based support services. It amends pretrial release procedures to require courts to consider approved community support providers for services like substance abuse treatment, mental health care, or case management as part of release conditions. The program directly affects defendants facing pretrial detention who qualify for release but may need additional support to comply with conditions. Key provisions mandate courts to include these services as a non-monetary release condition when appropriate, prioritizing the least restrictive options to ensure court appearance and community safety.
S 800 requires all New Jersey general acute care hospitals to include fentanyl testing in standard urine drug screenings used for patient diagnosis. Currently, these screenings typically test for drugs like cocaine and some opioids but not fentanyl. The bill mandates this change to help identify fentanyl exposure - often unintentional due to drug contamination - and ensure patients receive appropriate overdose treatment. The requirement takes effect immediately and expires on January 1, 2028.
This bill would require New Jersey Medicaid to cover family-based counseling services as part of substance use disorder treatment for eligible beneficiaries. It amends existing Medicaid coverage rules to specifically include these counseling services under authorized treatments provided in licensed facilities meeting state requirements. The policy would directly affect Medicaid recipients receiving substance use disorder care who would now have access to family-involved treatment options. Coverage would apply to both inpatient and outpatient settings where such services are prescribed by a physician.
New Jersey's S 2038 creates a pilot program for behavioral health courts, allowing eligible defendants to receive court-ordered treatment instead of prison sentences. The bill applies to individuals convicted of non-violent offenses who need behavioral health services (e.g., mental health or substance abuse treatment), have no prior violent convictions, and meet specific criteria like not possessing firearms during the offense. Courts must order participants into licensed treatment programs and monitor compliance, with probation revoked for violations (permanent revocation after a second violation). The program is limited to counties/municipalities that apply and operates as a pilot in at least two counties and five municipalities.
S 3128 requires New Jersey county health departments to maintain a reserve stock of opioid antidotes (like naloxone) to provide to specific entities - such as emergency medical services, substance abuse programs, and schools with approved policies - when their regular supply runs low. This directly affects county health departments, which must manage the reserve, and the designated entities that can receive the antidotes under the bill. The key mechanism creates a backup supply system to prevent interruptions in access to opioid antidotes during overdose emergencies. The bill aims to ensure continuous availability of these life-saving medications without expanding new access pathways.